# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price targe...
Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector Perform and raises the price...
2024 GUIDANCESabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted co...
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate o...
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said if you are looking for a stock that’s o...
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.33 per share which met the analyst consensus estimate. ...
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly sales of $163.40 million which beat the analyst consensus estimate of $...